{"id":"1fd7424c-5716-545e-ac41-8d498fa47a53","stable_key":"1b599eb7-b22a-5fda-bcf0-9d92b5ae1311:gb-immune-cells-make-their-own-gaba","predicate":"produces","statement":"Immune cells synthesize GABA and have the machinery for GABA catabolism, antigen-presenting cells express functional GABA receptors and respond electrophysiologically to GABA, thus the immune system harbors all of the necessary constituents for GABA signaling and GABA itself may function as a paracrine or autocrine factor, increasing GABAergic activity ameliorates ongoing paralysis in experimental autoimmune encephalomyelitis via inhibition of inflammation, and GABAergic agents act directly on antigen-presenting cells decreasing MAPK signals and diminishing subsequent adaptive inflammatory responses to myelin proteins.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"fada8db4-ded4-5da5-927e-8d0ef652c29b","mechanism_event_label":"The immune system has the whole apparatus to make and break down this transmitter, and uses it on itself.","subject":{"id":"1ab872d4-bee0-56b9-8e2f-6f62e30f4f50","slug":"antigen-presenting-cell","display_name":"Antigen-presenting cell","entity_type_key":"cell_type"},"object":{"id":"d5b98fa8-0612-5a5a-aa3c-6cfd8ff88867","slug":"gaba","display_name":"Gamma-aminobutyric acid","entity_type_key":"small_molecule"},"evidence_count":1,"mechanism_event":{"id":"fada8db4-ded4-5da5-927e-8d0ef652c29b","stable_key":"1b599eb7-b22a-5fda-bcf0-9d92b5ae1311:gb-immune-cells-make-their-own-gaba-event","event_type":"biochemical_relationship","label":"The immune system has the whole apparatus to make and break down this transmitter, and uses it on itself.","description":"Immune cells synthesize GABA and have the machinery for GABA catabolism, antigen-presenting cells express functional GABA receptors and respond electrophysiologically to GABA, thus the immune system harbors all of the necessary constituents for GABA signaling and GABA itself may function as a paracrine or autocrine factor, increasing GABAergic activity ameliorates ongoing paralysis in experimental autoimmune encephalomyelitis via inhibition of inflammation, and GABAergic agents act directly on antigen-presenting cells decreasing MAPK signals and diminishing subsequent adaptive inflammatory responses to myelin proteins.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"a5e842ec-6951-54fa-bf1c-2fed8247b40f","slug":"eae","display_name":"Experimental autoimmune encephalomyelitis","entity_type_key":"cellular_process"},"role":"treated_model","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"4fccf554-4caa-5e0e-a51e-062a1d612731","slug":"mapk-signalling","display_name":"MAPK signalling","entity_type_key":"cellular_process"},"role":"reduced_pathway","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"5e42971b-427f-5b32-968b-870b347135ab","slug":"gaba-a-receptors","display_name":"GABA-A receptor anion channels","entity_type_key":"protein_family"},"role":"expressed_receptor","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"9ef4e03f-a3be-55c6-90cb-4db1381e340c","slug":"human-abat","display_name":"Human GABA transaminase / ABAT","entity_type_key":"protein"},"role":"catabolic_enzyme","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"1ab872d4-bee0-56b9-8e2f-6f62e30f4f50","slug":"antigen-presenting-cell","display_name":"Antigen-presenting cell","entity_type_key":"cell_type"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"d5b98fa8-0612-5a5a-aa3c-6cfd8ff88867","slug":"gaba","display_name":"Gamma-aminobutyric acid","entity_type_key":"small_molecule"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/gaba-research/20133656.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"15fc62882eb9a9c1f5daad1bd2845bc99c94f1cf076620badc55b6be390e35fd\", \"start_char\": 0, \"end_char\": 896, \"text_sha256\": \"15fc62882eb9a9c1f5daad1bd2845bc99c94f1cf076620badc55b6be390e35fd\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Demonstration of GABA synthesis and catabolism machinery in immune cells with electrophysiology and an autoimmune disease model","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Increasing GABAergic activity in established experimental autoimmune encephalomyelitis","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The disease effect is on ongoing paralysis rather than prevention. The assignment to antigen-presenting cells rests on direct effects measured on those cells.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in.","comparator":null,"unit":null,"notes":"","entity":{"slug":"gaba","display_name":"Gamma-aminobutyric acid","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"Mouse","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The immune system has the whole apparatus to make and break down this transmitter, and uses it on itself.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[gb-p20133656] Inhibitory role for GABA in autoimmune inflammation. (2010). https://pubmed.ncbi.nlm.nih.gov/20133656/ DOI: 10.1073/pnas.0915139107","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Antigen-presenting cell and central nervous system","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"f0893161-121e-5ceb-9c44-a72588473c08","evidence_kind":"source_excerpt","locator":"Lines 547-558","start_line":547,"end_line":558,"excerpt":"### gb-immune-cells-make-their-own-gaba\nImmune cells synthesize GABA and have the machinery for GABA catabolism, antigen-presenting cells express functional GABA receptors and respond electrophysiologically to GABA, thus the immune system harbors all of the necessary constituents for GABA signaling and GABA itself may function as a paracrine or autocrine factor, increasing GABAergic activity ameliorates ongoing paralysis in experimental autoimmune encephalomyelitis via inhibition of inflammation, and GABAergic agents act directly on antigen-presenting cells decreasing MAPK signals and diminishing subsequent adaptive inflammatory responses to myelin proteins.\nCondition category: normal\nnutrient_topic: GABA research collection; topical membership is not evidence of a direct clinical effect, and the sign of a GABA response depends on the chloride gradient of the cell it was measured in.\nplain_language: The immune system has the whole apparatus to make and break down this transmitter, and uses it on itself.\norganism: Mouse\ntissue_or_cell_type: Antigen-presenting cell and central nervous system\nexperimental_model: Demonstration of GABA synthesis and catabolism machinery in immune cells with electrophysiology and an autoimmune disease model\nlimitations: The disease effect is on ongoing paralysis rather than prevention. The assignment to antigen-presenting cells rests on direct effects measured on those cells.\nexposure: Increasing GABAergic activity in established experimental autoimmune encephalomyelitis\nevidence_span: {\"source_cache\": \"artifacts/gaba-research/20133656.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"15fc62882eb9a9c1f5daad1bd2845bc99c94f1cf076620badc55b6be390e35fd\", \"start_char\": 0, \"end_char\": 896, \"text_sha256\": \"15fc62882eb9a9c1f5daad1bd2845bc99c94f1cf076620badc55b6be390e35fd\"}\n[gb-p20133656] Inhibitory role for GABA in autoimmune inflammation. (2010). https://pubmed.ncbi.nlm.nih.gov/20133656/ DOI: 10.1073/pnas.0915139107","model_system":"Demonstration of GABA synthesis and catabolism machinery in immune cells with electrophysiology and an autoimmune disease model","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [gb-p20133656] Inhibitory role for GABA in autoimmune inflammation. (2010). https://pubmed.ncbi.nlm.nih.gov/20133656/ DOI: 10.1073/pnas.0915139107","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"197c25bb-45fa-5e97-b3ab-2d2eff4e0d0a","stable_key":"import-1b599eb7-b22a-5fda-bcf0-9d92b5ae1311","title":"GABA: a ligand with no sign of its own, the cofactor that limits its synthesis, the barrier that keeps it out of the brain, and the immune settings where the same molecule protects and harms (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"07e36027ff70dbbe5563cddfa4758fd9b9b6eec148faecccafd476900b770456","revision_id":"a12d61de-f189-5bda-af3d-f31a1e61bccf","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}